Collin H.

Collin H. is currently the Director of Cell & Vector Engineering at ShapeTX. Prior to this, they were an Associate Director - Cell And Vector Engineering at Shape Therapeutics Inc. from April 2021 to January 2022. Collin has also held positions as a Senior Principal Scientist at Bristol Myers Squibb from November 2020 to April 2021, a Senior Scientist - Cell Therapy Development at Bristol Myers Squibb from August 2019 to November 2020, a Research Scientist - Protein Sciences at Juno Therapeutics, Inc. from September 2017 to August 2019, a Senior Associate Scientist at Juno Therapeutics, Inc. from February 2016 to September 2017, and an Associate Scientist, Discovery Research- Protein Sciences at Juno Therapeutics, Inc. from December 2014 to February 2016. Collin H. started their career as an Associate Scientist at Novo Nordisk from May 2014 to November 2014 and then became a Senior Research Associate at Novo Nordisk from October 2012 to March 2014. Collin was a Research Associate at Novo Nordisk from January 2010 to October 2012 and previously worked as a Research Associate at ZymoGenetics from December 2005 to December 2009.

Collin H. went to Seattle Pacific University.